Additionally, the ACC, CHOL, uveal melanoma, and THYM cases with genetic alterations showed amplification of PTBP1, whereas all diffuse large B-cell lymphoma, KIRP, and PAAD cases with genetic alterations showed mutations in PTBP1 (Fig. 3a). This evidence concerns the gene PTBP1 and pancreatic adenocarcinoma.